Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: May 28, 2023

Chartwell Rx Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has one hundred and ninety-six approved drugs.

Summary for Chartwell Rx
US Patents:0

Drugs and US Patents for Chartwell Rx

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx ATOVAQUONE atovaquone SUSPENSION;ORAL 207833-001 Apr 28, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx GLIPIZIDE glipizide TABLET;ORAL 074542-002 Jun 20, 1995 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx ALENDRONATE SODIUM alendronate sodium TABLET;ORAL 075871-002 Apr 22, 2009 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx PREDNISOLONE prednisolone TABLET;ORAL 084542-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx FULVICIN P/G griseofulvin, ultramicrocrystalline TABLET;ORAL 061996-002 Approved Prior to Jan 1, 1982 RX No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx SIMVASTATIN simvastatin TABLET;ORAL 077766-002 Dec 20, 2006 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.